This compound is a boronic ester derivative used as a pharmaceutical intermediate. It is primarily employed in the synthesis of active pharmaceutical ingredients, particularly those involving pyrazole-based structures.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 847818-74-0
[1,1'-Biphenyl]-4,4'-dicarboxylic acid
Pharmaceutical intermediate
(4S)-5-(tert-butoxy)-4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-oxopentanoic acid
pharmaceutical intermediate
4-(Dimethylamino)-2-butenoic acid hydrochloride
Pharmaceutical intermediate for API synthesis
N-(3-Cyano-7-ethoxy-4-hydroxyquinolin-6-yl)acetamide
pharmaceutical intermediate
1-(Propan-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
pharmaceutical intermediate
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrazole
research compound
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Research reagent for organic synthesis
1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole
HLXOVAMYQUFLPE-UHFFFAOYSA-N
B1(OC(C(O1)(C)C)(C)C)C2=CC=NN2C
—